- JAZZ has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $93.3 million.
- JAZZ is up 4% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in JAZZ with the Ticky from Trade-Ideas. See the FREE profile for JAZZ NOW at Trade-Ideas More details on JAZZ: Jazz Pharmaceuticals Public Limited Company, a specialty biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various medical needs in the United States, Europe, and internationally. JAZZ has a PE ratio of 114.5. Currently there are 9 analysts that rate Jazz Pharmaceuticals a buy, no analysts rate it a sell, and 2 rate it a hold. The average volume for Jazz Pharmaceuticals has been 816,200 shares per day over the past 30 days. Jazz has a market cap of $8.3 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.38 and a short float of 2.9% with 2.81 days to cover. Shares are up 8.9% year-to-date as of the close of trading on Monday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.